Related references
Note: Only part of the references are listed.Tissue regeneration as next-generation therapy for COPD – potential applications
Noritoshi Nagaya
International Journal of Chronic Obstructive Pulmonary Disease (2016)
The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism
J. van Mastbergen et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2012)
Depression in Chronic Obstructive Pulmonary Disease A Common Concomitant Disease
Paul W. Jones
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Statin Reverses Smoke-induced Pulmonary Hypertension and Prevents Emphysema but Not Airway Remodeling
Joanne L. Wright et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Behavioral and Structural Differences in Migrating Peripheral Neutrophils from Patients with Chronic Obstructive Pulmonary Disease
Elizabeth Sapey et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Agonist-Promoted Homologous Desensitization of Human Airway Smooth Muscle Bitter Taste Receptors
Kathryn S. Robinett et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents
Akihiro Sugawara et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans
Aili L. Lazaar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi
Maria G. Matera et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Is a regenerative approach viable for the treatment of COPD?
Matthew Hind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
β2-adrenoceptor agonists: current and future direction
Mario Cazzola et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
p38 Mitogen-Activated Protein Kinase Pathways in Asthma and COPD
Kian Fan Chung
CHEST (2011)
The COPD Pipeline X
Nicholas J. Gross
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2011)
A new nitrosyl ruthenium complex nitric oxide donor presents higher efficacy than sodium nitroprusside on relaxation of airway smooth muscle
Patricia F. S. Castro et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation
Daniela Impellizzeri et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis
Andrea Mencarelli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Symptom variability in patients with severe COPD: a pan-European cross-sectional study
R. Kessler et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Novel IκκB kinase inhibitors for treatment of nuclear factor-κκB-related diseases
Jun-ichi Suzuki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Neutrophil elastase inhibitors
William C. Groutas et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Bitter taste receptors as a target for bronchodilation
Sheila A. Doggrell
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease
David S. Millan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Azithromycin for Prevention of Exacerbations of COPD
Richard K. Albert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Therapeutic potential of adenosine analogues and conjugates
Monika Samsel et al.
PHARMACOLOGICAL REPORTS (2011)
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro
Nikola Marjanovic et al.
PHARMACOLOGICAL RESEARCH (2011)
Immunomodulatory Effects of Macrolide Antibiotics - Part 1: Biological Mechanisms
J. Altenburg et al.
RESPIRATION (2011)
Bronchodilatory effects of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients
Charles Fogarty et al.
RESPIRATORY MEDICINE (2011)
MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease
Jonathan A. Bernstein et al.
RESPIRATORY MEDICINE (2011)
PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease
Zuzana Diamant et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2011)
24-hour Bronchodilation following a single dose of the novel β2-agonist olodaterol in COPD
J. A. van Noord et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2011)
EP4 receptor as a new target for bronchodilator therapy
James Buckley et al.
THORAX (2011)
Novel bronchodilators for the treatment of chronic obstructive pulmonary disease
Maria Gabriella Matera et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Efficacy of indacaterol in the treatment of patients with COPD
Paul W. Jones et al.
PRIMARY CARE RESPIRATORY JOURNAL (2011)
Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review
Dongmei Wu et al.
RESPIRATORY RESEARCH (2011)
Biophysics of selectin-ligand interactions in inflammation and cancer
Luthur Siu-Lun Cheung et al.
PHYSICAL BIOLOGY (2011)
Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
Anthony D'Urzo et al.
RESPIRATORY RESEARCH (2011)
PI3K inhibition in inflammation: Toward tailored therapies for specific diseases
Alessandra Ghigo et al.
BIOESSAYS (2010)
Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease
Kori L. Wallace et al.
BLOOD (2010)
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives
Qian Zhou et al.
CIRCULATION JOURNAL (2010)
The COPD Pipeline
Nicholas J. Gross
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2010)
Phosphoinositide 3-kinase γ required for lipopolysaccharide-induced transepithelial neutrophil trafficking in the lung
J. Reutershan et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects
O. Holz et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Macrolide antibiotics and the airway: antibiotic or non-antibiotic effects?
D. M. Murphy et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Selectin inhibitors: a patent review
Patricia W. Bedard et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
PPARs as therapeutic targets in cardiovascular disease
Marc van Bilsen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Leukotriene B4 Is a Physiologically Relevant Endogenous Peroxisome Proliferator-activated Receptor-α Agonist
Venkata R. Narala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inhalation by Design: Novel Ultra-Long-Acting β2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup
Paul A. Glossop et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor Antagonist
G. Villetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Mechanisms and resistance in glucocorticoid control of inflammation
Peter J. Barnes
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction
Deepak A. Deshpande et al.
NATURE MEDICINE (2010)
New Therapies for Chronic Obstructive Pulmonary Disease
Peter J. Barnes
MEDICAL PRINCIPLES AND PRACTICE (2010)
Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents and non-human primates
Alexandra Hicks et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients
C. Verkindre et al.
RESPIRATORY MEDICINE (2010)
Doxofylline: A Novofylline
Clive P. Page
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
TNF-α inhibitors in asthma and COPD: We must not throw the baby out with the bath water
Maria Gabriella Matera et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD
Mario Cazzola et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
Retinoid treatment of Emphysema in Patients on the Alpha-1 International Registry. The REPAIR study: study design, methodology and quality control of study assessments
Jan Stolk et al.
Therapeutic Advances in Respiratory Disease (2010)
Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease
John A. Marwick et al.
Therapeutic Advances in Respiratory Disease (2010)
Pharmacological Characterization of Olodaterol, a Novel Inhaled β2-Adrenoceptor Agonist Exerting a 24-Hour-Long Duration of Action in Preclinical Models
T. Bouyssou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
INDACATEROL FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
M. Cazzola et al.
DRUGS OF TODAY (2010)
Clarithromycin Prevents Smoke-induced Emphysema in Mice
Yutaka Nakanishi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The Cytokine Network in Chronic Obstructive Pulmonary Disease
Peter J. Barnes
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
The K+ channels KCa3.1 and Kv1.3 as novel targets for asthma therapy
Peter Bradding et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease
Katharine H. Banner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease
Maria G. Belvisi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Targeting protein kinases for the development of anti-inflammatory drugs
Philip Cohen
CURRENT OPINION IN CELL BIOLOGY (2009)
A controlled trial of 6-weeks' treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD
J. Vestbo et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells
R. Gosens et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Systemic manifestations and comorbidities of COPD
P. J. Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Emerging inhaled bronchodilators: an update
M. Cazzola et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease
Rosanne M. Seguin et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Recent developments in CCR2 antagonists
Mingde Xia et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
An engineered CX3CR1 antagonist endowed with anti-inflammatory activity
Karim Dorgham et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease
John Doukas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
Amadeu Gavalda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
Leonardo M. Fabbri et al.
LANCET (2009)
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Peter M. A. Calverley et al.
LANCET (2009)
Modulation of steroid activity in chronic inflammation: A novel anti-inflammatory role for curcumin (Retraction of vol 52, pg 987, 2008)
Saibal Biswas et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Targeting the NF-kappa B pathway in asthma and chronic obstructive pulmonary disease
Michael R. Edwards et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Attacking the multi-tiered proteolytic pathology of COPD: New insights from basic and translational studies
Uros V. Djekic et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi
Maria Gabriella Matera et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Associations between statins and COPD: a systematic review
Claudia C Dobler et al.
BMC Pulmonary Medicine (2009)
Pharmacological actions of statins: potential utility in COPD
R. P. Young et al.
EUROPEAN RESPIRATORY REVIEW (2009)
Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations
Terence A. R. Seemungal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
Jadwiga A. Wedzicha et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells
Charlotte K. Billington et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Retinoic acid-induced alveolar regeneration - Critical differences in strain sensitivity
Sian V. Stinchcombe et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Treating lung inflammation with agonists of the adenosine A(2A) receptor: promises, problems and potential solutions
M. A. Trevethick et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006-2008
Liping H. Pettus et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFκB/ERK-dependent mechanism
Mirella Profita et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Increased activation of p38 MAPK in COPD
T. Renda et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
S. Haag et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases
Puneet Chopra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Interfering with chemokines and chemokine receptors as potential new therapeutic strategies
Mario Milco D'Elios et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2008)
MK2: a novel molecular target for anti-inflammatory therapy
Senthil Duraisamy et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease:: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)
Gregory S. Thomas et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2008)
Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases
Gyorgy Hasko et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease
Samy Suissa et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2008)
Effect of the oral leukotriene B-4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease
L. Groenke et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2008)
被撤回的出版物: Modulation of steroid activity in chronic inflammation: A novel anti-inflammatory role for curcumin (Retracted Article. See vol 53, pg 309, 2009)
Saibal Biswas et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Different mitogen-activated protein kinase-dependent cytokine responses in cells of the monocyte lineage
Susan J. Tudhope et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The use of statins and lung function in current and former smokers
Jean I. Keddissi et al.
CHEST (2007)
Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease:: preclinical and clinical developments
Alexandra Hicks et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Cooperative regulation of GSK-3 by muscarinic and PDGF receptors is associated with airway myocyte proliferation
Reinoud Gosens et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro
Frank Buehling et al.
RESPIRATORY MEDICINE (2007)
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
D. J. Powrie et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
A novel, orally active CXCR1/2 receptor antagonist, sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation
Richard W. Chapman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Importance of phosphoinositide 3-kinase γ in the host defense against pneumococcal infection
Ulrich A. Maus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inhibition of tumor necrosis factor-α-inducible inflammatory genes by interferon-γ is associated with altered nuclear factor-κB transactivation and enhanced histone deacetylase activity
Stefan Keslacy et al.
MOLECULAR PHARMACOLOGY (2007)
Novel strategies for inhibition of the p38 MAPK pathway
Jiyan Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways
Gino Villetti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Muscarinic receptors mediate stimulation of human lung fibroblast proliferation
Sonja Matthiesen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Feasibility of retinoids for the treatment of emphysema study
Michael D. Roth et al.
CHEST (2006)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Potential therapeutic role for statins in respiratory disease
E. Hothersall et al.
THORAX (2006)
Validation of the anti-inflammatory properties of small molecule IκB kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle
Matthew C. Catley et al.
MOLECULAR PHARMACOLOGY (2006)
Pharmacological strategies for overcoming multidrug resistance
S. Nobili et al.
CURRENT DRUG TARGETS (2006)
Are phosphodiesterase 4 inhibitors just more theophylline?
Victoria Boswell-Smith et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation
MG Belvisi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Control by cholinergic mechanisms
K Racké et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Modulation of nitric oxide pathways: Therapeutic potential in asthma and chronic obstructive pulmonary disease
AE Redington
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Effect of clarithromycin on rhinovirus-16 infection in A549 cells
YJ Jang et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Novel signal transduction modulators for the treatment of airway diseases
PJ Barnes
PHARMACOLOGY & THERAPEUTICS (2006)
P-selectin glycoprotein ligand-1 (PSGL-1) is up-regulated on leucocytes from patients with chronic obstructive pulmonary disease
A Schumacher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke
PA Martorana et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal
JS Cadieux et al.
JOURNAL OF CELL SCIENCE (2005)
Mitogen-activated protein kinases and asthma
G Pelaia et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Is loaded breathing an inflammatory stimulus?
T Vassilakopoulos et al.
CURRENT OPINION IN CRITICAL CARE (2005)
An overview on biological mechanisms of PPARs
BP Kota et al.
PHARMACOLOGICAL RESEARCH (2005)
The biology of p38 kinase: A central role in inflammation
GL Schieven
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages
BG Cosio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD - A pilot study
DA Mahler et al.
CHEST (2004)
Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection
WC Tsai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
The multiple mediators of neurogenic smooth muscle relaxation
SI Said et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities
V Lagente et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
WQ Gan et al.
THORAX (2004)
Inhaled combination therapy with long-acting β2-agonists and corticosteroids in stable COPD
M Cazzola et al.
CHEST (2004)
Role of Rho-kinase in maintaining airway smooth muscle contractile phenotype
R Gosens et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
DE O'Donnell et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
COPD: is there light at the end of the tunnel?
PJ Barnes
CURRENT OPINION IN PHARMACOLOGY (2004)
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease
W Ning et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
BR Celli et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
The airway cholinergic system: physiology and pharmacology
K Racke et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2004)
Macrolide and occult infection in asthma
M Cazzola et al.
CURRENT OPINION IN PULMONARY MEDICINE (2004)
Adenosine: an endogenous regulator of innate immunity
G Hasko et al.
TRENDS IN IMMUNOLOGY (2004)
Chronic obstructive pulmonary disease: molecular and cellular mechanisms
PJ Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38
AR Clark et al.
FEBS LETTERS (2003)
Muscarinic acetylcholine receptors and airway diseases
FR Coulson et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Statin effects beyond lipid lowering-are they clinically relevant?
PO Bonetti et al.
EUROPEAN HEART JOURNAL (2003)
Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function
AM Hamad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease
D Spina
DRUGS (2003)
Therapy for chronic obstructive pulmonary disease in the 21st century
LE Donnelly et al.
DRUGS (2003)
Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response
JI Webster et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD
S Gompertz et al.
CHEST (2002)
Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line
JS Gill et al.
BIOMATERIALS (2002)
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease
M Saetta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia
J Branger et al.
JOURNAL OF IMMUNOLOGY (2002)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
Neural regulation of airway smooth muscle tone
BJ Canning et al.
RESPIRATION PHYSIOLOGY (2001)
Effects of the synthetic selectin inhibitor TBC1269 on tissue damage during acute Mannheimia haemolytica-induced pneumonia in neonatal calves
ZA Radi et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2001)
Chemokine receptors in airway disease: Which receptors to target?
C Owen
PULMONARY PHARMACOLOGY & THERAPEUTICS (2001)
The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C4-induced contractions in passively sensitized human airways
DT Schmidt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Inhibition of adhesion of human neutrophils and eosinophils to P-selectin by the sialyl Lewisx antagonist TBC1269:: Preferential activity against neutrophil adhesion in vitro
KL Davenpeck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils
N Flamand et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)